Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2021 1
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of Urinary Tract Infections with Canephron() in Germany: A Retrospective Database Analysis.
Höller M, Steindl H, Abramov-Sommariva D, Wagenlehner F, Naber KG, Kostev K. Höller M, et al. Antibiotics (Basel). 2021 Jun 8;10(6):685. doi: 10.3390/antibiotics10060685. Antibiotics (Basel). 2021. PMID: 34201264 Free PMC article.
The effects of Canephron() were adjusted for age, sex, insurance status, and Charlson comorbidity score (CCI). Results: 2320 Canephron() patients and 158,592 antibiotic patients were available for analysis. Compared to antibiotic prescription, Canephron() pre …
The effects of Canephron() were adjusted for age, sex, insurance status, and Charlson comorbidity score (CCI). Results: 2320 Canep
Phytotherapy (BNO 1045) of Acute Lower Uncomplicated Urinary Tract Infection in Women Normalizes Local Host Responses.
Butler DSC, Wagenlehner F, Höller M, Abramov-Sommariva D, Steindl H, Naber KG. Butler DSC, et al. Urol Int. 2023;107(8):778-784. doi: 10.1159/000531206. Epub 2023 Aug 4. Urol Int. 2023. PMID: 37544300 Free PMC article. Clinical Trial.
Increased antimicrobial resistance has created an urgent need for novel therapeutics and the phytotherapeutic drug BNO 1045 (Canephron N) has previously been shown to be noninferior to standard antimicrobial stewardship. ...
Increased antimicrobial resistance has created an urgent need for novel therapeutics and the phytotherapeutic drug BNO 1045 (Canephron
Non-Antibiotic Herbal Therapy (BNO 1045) versus Antibiotic Therapy (Fosfomycin Trometamol) for the Treatment of Acute Lower Uncomplicated Urinary Tract Infections in Women: A Double-Blind, Parallel-Group, Randomized, Multicentre, Non-Inferiority Phase III Trial.
Wagenlehner FM, Abramov-Sommariva D, Höller M, Steindl H, Naber KG. Wagenlehner FM, et al. Urol Int. 2018;101(3):327-336. doi: 10.1159/000493368. Epub 2018 Sep 19. Urol Int. 2018. PMID: 30231252 Free PMC article. Clinical Trial.
INTRODUCTION: This randomized, controlled, Phase III non-inferiority clinical trial aimed to determine whether herbal therapy with Canephron N (BNO 1045) is non-inferior to fosfomycin trometamol (FT) in treating acute lower uncomplicated urinary tract infections (uU …
INTRODUCTION: This randomized, controlled, Phase III non-inferiority clinical trial aimed to determine whether herbal therapy with Caneph